Handelsinvest Investeringsforvaltning »

Bridgebio Pharma shares owned by Handelsinvest Investeringsforvaltning

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Handelsinvest Investeringsforvaltning from 13F filings

Historical chart of Handelsinvest Investeringsforvaltning investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Handelsinvest Investeringsforvaltning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Handelsinvest Investeringsforvaltning

Quarter filed Position value Share count Share price at filing
2024-03-31 $151k 4.9k 30.90
2023-12-31 $300k 7.4k 40.41

More positions owned by Handelsinvest Investeringsforvaltning

Microsoft Corp Common Stock (MSFT)
NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Alphabet Common Stock (GOOGL)
Meta Platforms Common Stock (META)
JPMorgan Chase & Co Common Stock (JPM)
Eli Lilly & Co Common Stock (LLY)
Broadcom Common Stock (AVGO)
Visa Common Stock (V)
Mastercard Common Stock (MA)
UnitedHealth Group Common Stock (UNH)
Procter & Gamble Co/The Common Stock (PG)
Merck & Co Common Stock (MRK)
Alphabet Common Stock (GOOG)

View all positions for Handelsinvest Investeringsforvaltning

Top funds holding Bridgebio Pharma

Vanguard Group
Viking Global Investors
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Susquehanna International
Invesco
Geode Capital Management
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma